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This study compares the hematological values of the ovulation phase with the luteal phase of the 
menstrual cycle. Sixty subjects with 30 subjects each in the ovulation and luteal phases of the menstrual cycle 
were studied. Ethical clearance and informed consent w re obtained for the study. Hematological parameters of 
blood samples collected using aseptic technique wer analysed using the Swelab Alfa automatic hematology 
analyser. Granulocyte(x103/µL) value for the ovulation and luteal phases were 1.48±0.15 and 2.53 ±0.36 
respectively (p<0.05). The Granulocyte% for the ovulation and luteal phases were 33.34±2.46 and 45.81±2.93 
respectively (p<0.05). The Lymphocyte % for ovulation and luteal phases were 58.89±1.66 and 47.58±2.76 
respectively (p<0.05). The Mean platelet volume values for ovulation and luteal phases were 7.68±0.30 and 
8.06±0.31 respectively (p<0.001). The plateletcrit for ovulation and luteal phases were 0.14±0.02 and 
0.15±0.02 respectively (p<0.001). The Platelet Width Density for ovulation and luteal phases were 11.53±0.49 
and 12.13±0.48 respectively (p< 0.01). The Platelet Larger Cell Ratio for ovulation and luteal phases were 
15.46±1.82 and 18.04±1.78 respectively (p< 0.01). Red cell parameters remained unchanged in both phases of 
the menstrual cycle. Platelet and granulocyte parameters are the hematological changes observed in the 
ovulation phase when compared to the luteal phase. 
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The menstrual cycle connotes a series 
of utero-ovarian and hormonal events that 
occur in fertile women and other primates for 
the purpose of procreation. It is counted from 
the first day of menstrual bleeding and ends 
when the next period begins. It is divided into 
four phases: the menstruation phase, follicular 
phase, ovulation phase, and the luteal phase. 
The follicular phase is also called the 
proliferative phase because some hormones 
causes the lining of the uterus to grow, or 
proliferate, during this time. Through the 
influence of a rise in follicle stimulating 
hormone (FSH) during the first days of the 
cycle, a few ovarian follicles are stimulated. 
Ovarian follicles are present at birth and 
develop for the better part of a year in a 
process known as folliculogenesis. These 
follicles subsequently compete with each 
other for dominance (Losos et al., 2002). 
Ovulation is the event of the Graaffian’s 
follicle rupturing and releasing a mature 
ovum, which is picked by the fimbriae end of 
the oviduct. It usually occurs regularly, 
around day 14 of a 28-day menstrual cycle. 
A. OMOROGIUWA and E. E. EGBELUYA / Int. J. Biol. Chem. Sci. 8(4): 1853-1858, 2014 
 
 1854
Once released, the egg is capable of being 
fertilized for 20 to 24 hours before it begins to 
disintegrate (Young, 2006). It is the few days 
around ovulation that a woman is most fertile. 
The luteal phase is also called the secretory 
phase. During the luteal phase, the corpus 
luteum which is a solid body formed in the 
ovary after the egg has been released from the 
ovary continues to grow and produces 
significant amounts of hormones, particularly 
progesterone (Losos et al., 2002).  
Progesterone plays a vital role in making the 
endometrium receptive to implantation of the 
blastocyst and supportive of the early 
pregnancy. Besides, the rise in basal body 
temperature caused by progesterone can be 
used to predict ovulation (Weschler, 2002). 
Overall the menstrual cycle is characterized 
by cyclical fluctuations in the levels of 
Follicle stimulating hormone (FSH), 
Luteinizing hormone (LH), estrogen and 
progesterone. These fluctuations can affect 
hematological parameters. For instance, 
platelet function is periodically altered during 
the ovarian cycle due to the influence of 
progesterone and estrogen on Von Willebrand 
factor concentrations (Drici et al., 1996). 
Ovarian hormones also alter the immune 
system like depression of the suppressor T cell 
activity (Dixon et al., 1994). Human & animal 
studies suggest that there is a change in the 
distribution of immune cells during different 
phases of menstrual cycle (Pehlivanoglu et al., 
2001). The ovulation phase of the menstrual 
cycle is the marker for fertilization and it may 
have unique hematological values. This study 
compares the hematologic values in the 
ovulation and luteal phases of the menstrual 
cycle. 
 
MATERIALS AND METHODS 
Sixty (60) healthy female 
undergraduates with a 28 day menstrual cycle 
were studied. Thirty (30) of the subjects were 
in the late luteal phase while 30 subjects were 




Informed consent and ethical approval 
were obtained from the Research and Ethics 




Blood samples were collected under 
aseptic conditions from the ante-cubital vein 
by venepuncture into a specimen bottle 
containing the anticoagulant Ethylene 
Diamine Tetra acetic Acid (EDTA). Blood 
samples were analysed within 1-2 hours of 
collection using the Swelab Alfa automatic 
hematology analyser.  
 
Data analysis 
Red cell, white cell and platelet indices 
in the ovulation and luteal phases of the 
menstrual cycle were recorded and statistical 
analysis was done using the Student’s t-test, 
p<0.05 was considered significant. 
 
RESULTS 
In general, there was no statistical 
difference (p>0.05) in all red blood cell 
indices of the ovulation phase compared to the 
luteal phase of the menstrual cycle. However, 
the granulocyte, granulocyte percentage and 
lymphocyte percentage showed a significant 
difference (p<0.05) between these two phases 
of the menstrual cycle. Furthermore, platelet 
indices such as the Plateletcrit, Platelet width 
density and Platelet larger cell ratio of the 
ovulation phase was statistically different 
(p<0.05) from that of the luteal phase. 
 
Red cell indices 
The red cell indices considered for both 
the ovulation and luteal phases of the 
menstrual cycle are shown in Table 1. The 
reductions in values of Red Cell Count, Mean 
Corpuscular Volume Cell, Red Density width 
and Hematocrit luteal phase when compared 
to the values in the ovulation phase were only 
empirical, there was no statistical difference 
(p>0.05) between the values of these two 
phases of the menstrual cycle. 
A. OMOROGIUWA and E. E. EGBELUYA / Int. J. Biol. Chem. Sci. 8(4): 1853-1858, 2014 
 
 1855
White Blood cell indices 
The variation in the white cell indices 
of the ovulation phase when compared to the 
luteal phase is shown in Table 2. From this 
table, it is shown that there was a statistically 
significant (p<0.05)  rise in granulocyte count  
(2.53 ±0.36 x103/µL ) of the luteal phase 
when compared to that (1.48 ±0.15 x103/µL)  
of the ovulation phase of the menstrual cycle. 
As shown in table, there was also a 
statistically significant rise in the granulocyte 
percentage (45.81 ±2.93) of the luteal phase 
when compared to that (33.34 ±2.46) of the 
ovulation phase. Although the luteal phase 
(2.54 ±0.25 x103/µL) decrease in   lymphocyte 
count was not statistically different (p>0.05) 
from the ovulation value (2.70 ±0.23 x103/µL) 
the lymphocyte percentage (58.89 ±1.66) for 
the ovulation phase was statistically higher 




The platelet count and platelet indices 
of the ovulation and luteal phases of the 
menstrual cycle are shown in Table 3. Overall, 
the platelet count (196.80 ± 23.46 x103/ µL) 
for the luteal phase was not statistically 
different (p>0.05) from that (186.10 ± 18.54 
x103/ µL) of the ovulation phase. However, 
the platelet indices for the luteal phase 
compared to the ovulation phase showed 
statistical difference (p<0.05). 
   
 
Table 1: Red blood cell and related indices during the luteal and ovulation phases of the menstrual 
cycle.  
 
Parameter Ovulation phase Luteal phase t-value p-value 
Red Blood Cell (x106  /µL) 4.95 ± 0.16 4.92 ± 0.20 0.19 0.85 
Mean Corpuscular Volume (fL) 80.63 ± 2.72 79.58 ± 2.56 1.02 0.34 
Red Density width (fL) 59.76 ± 2.21 59.06 ± 1.94 0.46 0.66 
Hematocrit (%) 39.76 ± 1.33 39.05 ± 1.72 0.56 0.59 
Hemoglobin(g/dL) 10.97 ± 0.46 11.03 ± 0.36 0.67 0.52 
Mean Corpuscular hemoglobin 
(pg) 
22.25 ± 0.93 22.67 ± 0.95 0.95 0.37 
Mean Corpuscular hemoglobin 
concentration (g/dL) 
27.52 ± 0.41 28.47 ± 0.70 1.20 0.26 
*p < 0.05 Considered significant different in ovulation and luteal phase. 
 
 
Table 2: White Blood cell and related indices during the ovulation and luteal phases of the 
menstrual cycle. 
 
Parameter Ovulation phase Luteal phase t-value p-value 
White blood cell (x103/µL)  4.59 ±0.33 5.51 ±0.51 1.87 0.10 
Lymphocyte (x103/µL) 2.70 ±0.23 2.54 ±0.25 0.46 0.66 
Granulocyte (x103/µL) 1.48 ±0.15 2.53 ±0.36 2.59 0.03* 
Lymphocyte percentage 58.89 ±1.66 47.58 ±2.76 3.14 0.01* 
Granulocyte percentage 33.34 ±2.46 45.81 ±2.93 3.18 0.01* 
Mid sized cells (x103/µL) 0.41 ±0.06 0.44 ±0.08 1.78 0.11 
Mid sized cells percentage 7.77 ±1.40 6.61 ±0.93 1.47 0.18 
*p < 0.05 Considered significant different in ovulation and luteal phase. 
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Table 3: Platelets parameters and related indices during the ovulation and luteal phases of the 
menstrual cycle. 
 
Parameter Ovulation phase Luteal phase t-value p-value 
Platelet (x103/ µL) 196.80 ± 23.46 186.10 ± 18.54 0.91   0.39 
Mean platelet volume (fL) 7.68±0.30 8.06±0.31 5.28 <0.001*  
Platecrit (%) 0.14±0.02 0.15±0.02 9.00 <0.001* 
Platelet width density (fL) 11.53±0.49 12.13±0.48 3.66  0.01* 
Platelet larger cell ratio 15.46±1.82 18.04±1.78 4.22  0.002* 




The menstrual cycle is 
characteristically divided into four phases 
namely the menstruation, follicular, ovulation 
and luteal. Each of these phases has unique 
features. For instance, the menstrual phase is 
characterized by bleeding, the follicular phase 
is characterized by the ultimate growth of a 
graffian follicle, ovulation is characterized by 
the release of the ovum, while the luteal phase 
is characterized by the preparation of the 
reproductive organs for pregnancy. These 
phases may also have their characteristic 
hematological features. This study is restricted 
to the ovulation and luteal phases of the 
menstrual cycle. The red blood cell count, 
mean cell volume, red density width, 
hematocrit, hemoglobin concentration, mean 
corpuscular hemoglobin and mean cell 
hemoglobin concentration were essentially the 
same in the ovulation and luteal phases of the 
menstrual cycle. This is not unexpected 
because these phases of the menstrual cycle 
do not involve hemorrhage. However, Rajnee 
et al. (2010) reported that hemoglobin 
concentration might increase from menstrual 
phase to secretory phase due to increased 
erythropoiesis to compensate for the blood 
loss during menses. Hemoglobin and red 
blood cell count have been reported to 
increase from the early menstrual phase until 
the post-ovulatory period, with a subsequent 
decrease towards the end of the cycle 
(Harewood et al., 2000; Kim et al., 1993). 
Some studies showed that hemoglobin 
concentrations were significantly lower in 
follicular phase than in the luteal phase 
(Simmons and Butterworth, 1997; Loraine 
and Bell, 1963). In the present study, the total 
WBC count and the lymphocyte count showed 
no changes in the ovulation phase when 
compared to the luteal.  This is consistent with 
previous studies (Pathak et al., 1981; Pohle, 
1939; Makinoda et al., 1996).  This study 
revealed that the granulocyte was higher in the 
luteal phase when compared to the ovulation 
phase and this is conisitent with previous 
studies (Mathur et al., 1979). Estrogen seems 
to enhance granulocyte proliferation i  vitro 
and probably promotes the release of 
neutrophil from the bone marrow rather than 
from the marginated pool (Bain and England, 
1975). In the present study, significant 
increase was observed in Granulocyte and 
Granulocyte% in luteal phase compared to the 
ovulation phase. Significant increase was also 
observed on Lymphocyte percentage in 
ovulation phase compared to luteal phase. 
Study showed increase in differential 
lymphocyte count during proliferative & 
secretory phase in comparison to menstrual 
phase probably due to increase in number of 
Helper T cells, cytotoxic T cells & Natural 
killer cells (Faas et al., 2000), that occurs 
under the influence of steroids. This study 
also revealed that platelet indices mean 
platelet volume, plateletcrit, platelet density 
width and platelet larger cell ratio showed 
significant increase in luteal phase compared 
to ovulation phase. This may be induced by 
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phasic changes in female sex steroids, 
endometrial shedding, blood loss and 
inflammatory-like process during ovulation 
and shifting of immune response from type 1 
to type 2 during the luteal phase (Dixon et al., 
1994). Studies also indicate that platelet 
function is periodically altered during 
menstrual cycle due to the influence of 
progesterone and estrogen on Von Willebrand 
factors concentration (Feuring et al., 2002). 
 
Conclusion 
We conclude that granulocyte, 
granulocyte percentage, mean platelet volume, 
plateletcrit, platelet width density and platelet 
larger cell ratio are significantly lower in the 
ovulation phase when compared to the luteal 
phases of the menstrual cycle. Whereas 
lymphocyte percentage was significantly 
higher in the ovulation phase compared to the 
luteal phase. This observation may be induced 
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